We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+7.44%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$641M
AUM Growth
+$24.9M
Cap. Flow
+$1.45M
Cap. Flow %
0.23%
Top 10 Hldgs %
63.54%
Holding
112
New
15
Increased
10
Reduced
10
Closed
8
Avg Time Held
1 year
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
MDXH icon
MDxHealth
MDXH
+$19.2M
2
OPTN icon
OptiNose
OPTN
+$8.3M
3
BC icon
Brunswick
BC
+$6.12M
4
TV icon
Televisa
TV
+$3.59M
5
IHC
Independence Holding Company
IHC
+$2.92M

Sector Composition

Rank Sector Weight
1 Healthcare 25.72%
2 Industrials 16.1%
3 Financials 14.02%
4 Miscellaneous 13.09%
5 Consumer Discretionary 11.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GLD icon
1
SPDR Gold Trust
GLD
$141B
$81.2M 12.68%
475,000
– –
2019 Q4
8 quarters
LIN icon
2
Linde
LIN
$229B
$66.7M 10.42%
192,627
– –
2019 Q4
8 quarters
INVE icon
3
INVE Technologies, Inc. Common Stock
INVE
$55.3M
$61.8M 9.65%
2,196,389
– –
2019 Q4
8 quarters
BC icon
4
Brunswick
BC
$4.18B
$56.7M 8.84%
562,500
+62,500
+13% +$6.12M
2020 Q1
7 quarters
RPRX icon
5
Royalty Pharma
RPRX
$26.8B
$32.8M 5.13%
824,033
-291,947
-26% -$11.3M
2020 Q2
6 quarters
DRRX icon
6
DELISTED
DURECT Corp
DRRX
$26M 4.06%
2,641,466
– –
2019 Q4
8 quarters
IVAC icon
7
DELISTED
Intevac Inc
IVAC
$23.3M 3.64%
4,949,355
– –
2019 Q4
8 quarters
PACX
8
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$21M 3.27%
2,125,000
– –
2021 Q2
2 quarters
SPGI icon
9
S&P Global
SPGI
$123B
$18.9M 2.95%
40,000
– –
2019 Q4
8 quarters
MDXH icon
10
MDxHealth
MDXH
$58.1M
$18.6M 2.91%
+1,958,333
New +$19.2M
2021 Q4
0 quarters
HLTH icon
11
DELISTED
Cue Health Inc. Common Stock
HLTH
$13.4M 2.09%
1,000,000
– –
2021 Q3
1 quarter
TCDA
12
DELISTED
Tricida, Inc. Common Stock
TCDA
$13.1M 2.04%
1,367,353
+67,353
+5% +$434K
2021 Q3
1 quarter
MRNS icon
13
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12.6M 1.97%
1,062,500
– –
2020 Q1
7 quarters
LIQT icon
14
LiqTech
LIQT
$11.9M
$12.4M 1.94%
271,994
+625
+0.2% +$27K
2020 Q1
7 quarters
CORS
15
DELISTED
Corsair Partnering Corporation
CORS
$12.2M 1.9%
1,250,000
– –
2021 Q3
1 quarter
LSXMK icon
16
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$12M 1.88%
305,187
– –
2019 Q4
8 quarters
THO icon
17
Thor Industries
THO
$3.62B
$11.4M 1.78%
109,753
– –
2020 Q1
7 quarters
BX icon
18
Blackstone
BX
$84.6B
$10.4M 1.62%
80,000
– –
2019 Q4
8 quarters
ISLE
19
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$9.84M 1.54%
1,000,000
– –
2021 Q1
3 quarters
IDN icon
20
Intellicheck
IDN
$45.6M
$9.58M 1.5%
2,073,583
– –
2019 Q4
8 quarters
FNCH icon
21
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$8.08M 1.26%
27,014
– –
2021 Q1
3 quarters
CDXS icon
22
Codexis
CDXS
$148M
$6.25M 0.98%
200,000
-379,116
-65% -$12.5M
2019 Q4
8 quarters
OPTN icon
23
DELISTED
OptiNose
OPTN
$6.03M 0.94%
+248,013
New +$8.3M
2021 Q4
0 quarters
SONO icon
24
Sonos
SONO
$2.09B
$5.45M 0.85%
182,951
-33,449
-15% -$1.06M
2020 Q4
4 quarters
LSXMA icon
25
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$5.27M 0.82%
141,002
– –
2020 Q2
6 quarters

Similar funds

Bleichroeder LP's Q4 2021 Portfolio in Review

As of Q4 2021, Bleichroeder LP held 112 positions worth $641M, up 4% from $616M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Bleichroeder LP's Q4 2021 filing shows 15 new, 10 increased, 10 reduced and 8 closed positions. Its largest new stake was MDxHealth: 1,958,333 shares worth $18.6M. The largest sale was Codexis, an estimated $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Industrials and Financials.

  • Bleichroeder LP's largest Q4 2021 buy was MDxHealth: 1,958,333 shares worth $18.6M.
  • Bleichroeder LP added most to Brunswick in Q4 2021, an estimated $6.12M increase.
  • Bleichroeder LP's biggest Q4 2021 reduction was Codexis, cutting an estimated $12.5M.
  • Bleichroeder LP fully exited EQRx, Inc. Common Stock in Q4 2021, selling an estimated $9.92M.
  • Bleichroeder LP's ten largest holdings make up 64% of its $641M portfolio in Q4 2021.
  • Bleichroeder LP opened 15 new positions and closed 8 in Q4 2021.
  • Bleichroeder LP's portfolio value rose 4% quarter-over-quarter to $641M.

Based on Bleichroeder LP's 13F filing for Q4 2021, filed 10 Feb 2022.